• Contact info@abtriva.com for inquiries and orders.
  • Chinese (Simplified)

  • English

  • German

  • Korean

  • Spanish

United States (English / $ USD)

Recombinant Human Dynein heavy chain 8, axonemal (DNAH8), Truncated

ACP14683

Number
Order Exclusive Products Now

Request a Quote
High Purity LevelsPrecision and ReliabilityCustomization Options

Specifications


Cat.No ACP14683 Target NameDNAH8
Target SynonymsDNAH8Dynein heavy chain 8; axonemal; Axonemal beta dynein heavy chain 8; Ciliary dynein heavy chain 8FormLyophilized powder
Expression SystemCustom Production. Please inquire and provide the desire expression system.Protein LengthPartial
Purity>85% (SDS-PAGE)Storage Buffer5%-50% glycerol. Lyophilized powder form: the buffer before lyophilization is Tris/PBS-based buffer, 6% Trehalose, Liquid form: default storage buffer is Tris/PBS-based buffer, pH 8.0.

Immunogen Information


Target SpeciesHumanUniprot IDQ96JB1
Background Information
  • Uniprot Id

    Q96JB1

  • Target Species

    Human

  • Target Name

    DNAH8

  • Target Full Name

    Dynein axonemal heavy chain 8

  • Target Function

    Force generating protein component of the outer dynein arms (ODAs) in the sperm flagellum. Produces force towards the minus ends of microtubules. Dynein has ATPase activity; the force-producing power stroke is thought to occur on release of ADP. Involved in sperm motility; implicated in sperm flagellar assembly.

  • Target Subcellular Location

    Cytoplasm, cytoskeleton, flagellum axoneme. Cytoplasm.

  • Target Protein Families

    Dynein heavy chain family

  • Target Tissue Specificity

    Expressed in spermatozoa (at protein level). Not detected in airway epithelial cells (at protein level).

  • Target Synonyms

    DNAH8Dynein heavy chain 8; axonemal; Axonemal beta dynein heavy chain 8; Ciliary dynein heavy chain 8

Inquire Recombinant Human Dynein heavy chain 8, axonemal (DNAH8), Truncated Now



AbTriva respects your privacy and protects your personal data in accordance with AbTriva. For more information, please see our data protection statement. *

Notification